These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9238440)

  • 41. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.
    Hallak LK; Collins PL; Knudson W; Peeples ME
    Virology; 2000 Jun; 271(2):264-75. PubMed ID: 10860881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glycosaminoglycans bind granulocyte-macrophage colony-stimulating factor and modulate its mitogenic activity and signaling in human osteoblastic cells.
    Modrowski D; Lomri A; Marie PJ
    J Cell Physiol; 1998 Oct; 177(1):187-95. PubMed ID: 9731758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytokine-induced expansion of human CD34+ stem/progenitor and CD34+CD41+ early megakaryocytic marrow cells cultured on normal osteoblasts.
    Ahmed N; Khokher MA; Hassan HT
    Stem Cells; 1999; 17(2):92-9. PubMed ID: 10195569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regeneration of megakaryocytopoiesis and thrombopoiesis in vitro from X-irradiated human hematopoietic stem cells.
    Kashiwakura I; Inanami O; Abe Y; Satoh K; Takahashi TA; Kuwabara M
    Radiat Res; 2006 Aug; 166(2):345-51. PubMed ID: 16881735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Control of megakaryocyte development: from basic data to clinical results.
    Caen JP; Han ZC
    C R Acad Sci III; 1993 Sep; 316(9):919-30. PubMed ID: 8076217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effect of erythropoietin on megakaryocytopoiesis depressed by dialysable substances in experimental animals].
    Zorcheva R; Nenov D; Diankov E
    Eksp Med Morfol; 1994; 32(3-4):49-56. PubMed ID: 8857032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The physiological function of heparin.
    Koller F
    Thromb Diath Haemorrh; 1975 Feb; 33(1):17-9. PubMed ID: 1118830
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of certain reducing agents on the anti-thrombic action of heparin.
    GREEN J
    Biochem J; 1953 Jul; 55(320th Meeting):xxiii. PubMed ID: 13093707
    [No Abstract]   [Full Text] [Related]  

  • 49. Function of heparin.
    RILEY JF; SHEPHERD DM; WEST GB; STROUD SW
    Nature; 1955 Dec; 176(4493):1123. PubMed ID: 13272756
    [No Abstract]   [Full Text] [Related]  

  • 50. [Therapeutic applications of heparin].
    FOA C
    Resen Clin Cient; 1950 Nov; 19(11):427-30. PubMed ID: 14808687
    [No Abstract]   [Full Text] [Related]  

  • 51. [Therapeutic applications of heparin].
    FOA C
    Resen Clin Cient; 1950 Oct; 19(10):385-8; contd. PubMed ID: 14808683
    [No Abstract]   [Full Text] [Related]  

  • 52. Bacteriostatic action of heparin.
    STOKER SB
    J Physiol; 1949 Dec; 110(1-2):Proc, 26. PubMed ID: 15406425
    [No Abstract]   [Full Text] [Related]  

  • 53. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE; Erickson-Miller CL; Murphy MJ
    Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced growth of megakaryocyte colonies in culture in the presence of heparin and fibroblast growth factor.
    Chen QS; Wang ZY; Han ZC
    Int J Hematol; 1999 Oct; 70(3):155-62. PubMed ID: 10561907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombopoietin: biology and clinical potentials.
    Miyazaki H; Kato T
    Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Thrombopoietin and megakaryocyte differentiation].
    Vainchenker W; Debili N; Norol F; Wendling F
    Schweiz Med Wochenschr; 1998 Oct; 128(42):1575-81. PubMed ID: 9824885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of heparin on megakaryocytopoiesis. From fundamental data to clinical applications].
    Bellucci S; Han ZC; Caen J
    Ann Med Interne (Paris); 1997; 148(2):150-3. PubMed ID: 9238440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth regulators.
    Han ZC; Bellucci S; Shen ZX; Maffrand JP; Pascal M; Petitou M; Lormeau J; Caen JP
    J Cell Physiol; 1996 Jul; 168(1):97-104. PubMed ID: 8647928
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.